Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marilisa Schiwek"'
Autor:
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young
Publikováno v:
ERJ Open Research, Vol 7, Iss 2 (2021)
Childhood interstitial lung disease (chILD) comprises >200 rare respiratory disorders, with no currently approved therapies and variable prognosis. Nintedanib reduces the rate of forced vital capacity (FVC) decline in adults with progressive fibrosin
Externí odkaz:
https://doaj.org/article/44d5db22b39344b2a8349a04d7f20b85
Autor:
Frank Risse, Marilisa Schiwek, Philip Konietzke, Jürgen Biederer, Oyunbileg von Stackelberg, Simon M. F. Triphan, Oliver Weinheimer, Monika Eichinger, Bertram J. Jobst, Mark O. Wielpütz, Rudolf A. Jörres, Claus Vogelmeier, Claus Peter Heußel, Hans-Ulrich Kauczor
Publikováno v:
European Radiology. 32:1879-1890
Objectives Pulmonary perfusion abnormalities are prevalent in patients with chronic obstructive pulmonary disease (COPD), are potentially reversible, and may be associated with emphysema development. Therefore, we aimed to evaluate the clinical meani
Autor:
Ulrike Schmid, Nicolaus Schwerk, Mihaela Dumistracel, Steven Cunningham, Kay Tetzlaff, Kevin R. Flaherty, Kevin K. Brown, Robin R. Deterding, David Warburton, Emmanuelle Clerisme-Beaty, Florian Voss, Gail H. Deutsch, Susanne Stowasser, Emily M. DeBoer, Lisa R. Young, Annick Clement, Matthias Griese, Daniela Verri, Rozsa Schlenker-Herceg, Marilisa Schiwek
Publikováno v:
Deterding, R, Griese, M, Deutsch, G, Warburton, D, DeBoer, E, Cunningham, S, Clement, A, Schwerk, N, Flaherty, K R, Brown, K K, Voss, F, Schmid, U, Schlenker-Herceg, R, Verri, D, Dumistracel, M, Schiwek, M, Stowasser, S, Tetzlaff, K, Clerisme-Beaty, E & Young, L R 2021, ' Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease ', ERJ Open Research . https://doi.org/10.1183/23120541.00805-2020
ERJ Open Research, Vol 7, Iss 2 (2021)
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 2 (2021)
ERJ Open Research
article-version (VoR) Version of Record
Childhood interstitial lung disease (chILD) comprises >200 rare respiratory disorders, with no currently approved therapies and variable prognosis. Nintedanib reduces the rate of forced vital capacity (FVC) decline in adults with progressive fibrosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca86d3042ae77819c9bb9e7f0b5f05d
https://www.pure.ed.ac.uk/ws/files/205704745/23120_1_.pdf
https://www.pure.ed.ac.uk/ws/files/205704745/23120_1_.pdf
Autor:
Jens Vogel-Claussen, Kathrin Hohl, Marilisa Schiwek, Maria Sarno, Christoph Czerner, Marcel Gutberlet, Abhya Gupta, Frank Risse, Heike Biller, Julius Renne, Jens M. Hohlfeld
Publikováno v:
Imaging.
Background: Segmental LPS challenge is used in studies which examine inflammation induced edema in the lung. Currently, bronchoalveolar lavage (BAL) is used to quantify the LPS-induced amount of inflammation. Objectives: MRI is investigated to quanti